ATE275152T1 - Die herstellung von biologisch aktiven, rekombinanten und neurotrophem protein - Google Patents

Die herstellung von biologisch aktiven, rekombinanten und neurotrophem protein

Info

Publication number
ATE275152T1
ATE275152T1 AT95918354T AT95918354T ATE275152T1 AT E275152 T1 ATE275152 T1 AT E275152T1 AT 95918354 T AT95918354 T AT 95918354T AT 95918354 T AT95918354 T AT 95918354T AT E275152 T1 ATE275152 T1 AT E275152T1
Authority
AT
Austria
Prior art keywords
neurotrophic factor
biologically active
production
recombinant
neurotrophic protein
Prior art date
Application number
AT95918354T
Other languages
English (en)
Inventor
Jack Lile
Tadahiko Kohno
Duane Bonam
Mary S Rosendahl
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of ATE275152T1 publication Critical patent/ATE275152T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT95918354T 1994-05-09 1995-05-02 Die herstellung von biologisch aktiven, rekombinanten und neurotrophem protein ATE275152T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24012294A 1994-05-09 1994-05-09
US08/266,080 US5606031A (en) 1990-04-06 1994-06-27 Production and purification of biologically active recombinant neurotrophic protein in bacteria
PCT/US1995/005423 WO1995030686A1 (en) 1994-05-09 1995-05-02 Production of biologically active recombinant neurotrophic protein

Publications (1)

Publication Number Publication Date
ATE275152T1 true ATE275152T1 (de) 2004-09-15

Family

ID=26933155

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95918354T ATE275152T1 (de) 1994-05-09 1995-05-02 Die herstellung von biologisch aktiven, rekombinanten und neurotrophem protein

Country Status (11)

Country Link
US (1) US5606031A (de)
EP (1) EP0772627B1 (de)
JP (1) JP3673278B2 (de)
AT (1) ATE275152T1 (de)
AU (1) AU697891B2 (de)
CA (1) CA2189659C (de)
DE (1) DE69533443T2 (de)
DK (1) DK0772627T3 (de)
ES (1) ES2230549T3 (de)
PT (1) PT772627E (de)
WO (1) WO1995030686A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE206056T1 (de) * 1992-06-08 2001-10-15 Takeda Chemical Industries Ltd Therapeutisches agens für neutropenie
US6299895B1 (en) 1997-03-24 2001-10-09 Neurotech S.A. Device and method for treating ophthalmic diseases
BR9713055A (pt) * 1996-11-15 2000-04-04 Genentech Inc Processo para isolar uma neurotrofina humana recombinante, composição de neurotrofina e processo para purificar uma neurotrofina
JP2002512370A (ja) * 1998-04-17 2002-04-23 イノジェネティックス・ナムローゼ・フェンノートシャップ 還元剤を用いる改良された免疫診断アッセイ
ATE257514T1 (de) * 1998-10-09 2004-01-15 Scil Proteins Gmbh Verfahren zur gewinnung von aktivem beta-ngf
US6451987B1 (en) * 1999-03-15 2002-09-17 Novo Nordisk A/S Ion exchange chromatography of proteins and peptides
US6444788B1 (en) * 1999-03-15 2002-09-03 Novo Nordisk A/S Ion exchange chromatography of GLP-1, analogs and derivatives thereof
US6458541B1 (en) 1999-08-11 2002-10-01 Whitehead Institute For Biomedical Research BDNF polymorphism and association with bipolar disorder
AU7061700A (en) 1999-08-17 2001-03-13 University Of Texas System, The Use of colostrinin, constituent peptides thereof, and analogs thereof as oxidative stress regulators
US6903068B1 (en) 1999-08-17 2005-06-07 Board Of Regents, The University Of Texas System Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines
US6852685B1 (en) 1999-08-17 2005-02-08 Board Of Regents, The University Of Texas System Use of colostrinin, constituent peptides thereof, and analogs thereof to promote neuronal cell differentiation
US7119064B2 (en) 1999-08-17 2006-10-10 Board Of Regents, The University Of Texas System Use of colostrinin, constituent peptides thereof, and analogs thereof as modulators of intracellular signaling molecules
US20020064835A1 (en) * 2000-07-10 2002-05-30 Diosynth Rtp, Inc. Purification of human troponin I
AU2000269179A1 (en) * 2000-08-17 2002-02-25 The University Of Texas System Use of colostrinin, constituent peptides thereof, and analogs thereof to promoteneural cell differentiation
DE10105912A1 (de) * 2001-02-09 2002-08-14 Roche Diagnostics Gmbh Rekombinante Proteinase K
US20030232365A1 (en) * 2001-02-15 2003-12-18 Whitehead Institute For Biomedical Research BDNF polymorphisms and association with bipolar disorder
EP1233075A3 (de) * 2001-02-15 2003-01-08 Whitehead Institute For Biomedical Research BDNF Polymorphismus und Vereinigung mit doppelpoliger Geistesgestörtheit
US20030012818A1 (en) * 2001-04-25 2003-01-16 Eidgenossische Technische Hochschule Zurich And Universitat Zurich Drug delivery matrices to enhance wound healing
CN105131104B (zh) 2001-10-10 2018-11-16 诺和诺德公司 肽的重构和糖缀合
SG155777A1 (en) 2003-04-09 2009-10-29 Neose Technologies Inc Glycopegylation methods and proteins/peptides produced by the methods
CA2532340A1 (en) * 2003-08-21 2005-03-03 Novo Nordisk A/S Separation of polypeptides comprising a racemized amino acid
WO2009083544A2 (en) * 2007-12-28 2009-07-09 Kuros Biosurgery Ag Pdgf fusion proteins incorporated into fibrin foams
CN103502464B (zh) 2010-12-02 2016-03-23 神经技术美国有限公司 分泌抗血管生成抗体支架和可溶性受体的细胞系及其用途
JP6850734B2 (ja) 2015-05-27 2021-03-31 ニューロテック ユーエスエー， インコーポレイテッド 眼の障害の処置のためのカプセル化細胞療法の使用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4223967A (en) * 1978-05-10 1980-09-23 Antonio Royer Telescopic structural element for making modular closets, partition walls, door supports and the like
US4421685A (en) * 1980-03-27 1983-12-20 Eli Lilly And Company Process for producing an insulin
US4511503A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4599197A (en) * 1982-12-22 1986-07-08 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4512922A (en) * 1982-12-22 1985-04-23 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4620948A (en) * 1982-12-22 1986-11-04 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4511502A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4518526A (en) * 1982-12-22 1985-05-21 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US5169762A (en) * 1983-03-03 1992-12-08 Genentech, Inc. Human nerve growth factor by recombinant technology
DK161152C (da) * 1983-03-03 1991-11-11 Genentech Inc Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat
US4451396A (en) * 1983-08-01 1984-05-29 Eli Lilly And Company Process for inhibiting undesired thiol reactions during cyanogen bromide cleavage of peptides
JPH01257491A (ja) * 1988-04-08 1989-10-13 Tosoh Corp 不溶性融合異種蛋白質の処理方法
US4923967A (en) * 1988-09-26 1990-05-08 Eli Lilly And Company Purification and refolding of recombinant proteins
US5180820A (en) * 1989-08-30 1993-01-19 Barde Yves Alain Brain-derived neurotrophic factor
IL95511A (en) * 1989-08-30 2000-10-31 Max Planck Gesellschaft Neurotrophin-3 a novel neurotrophic factor related to nerve growth and brain derived neurotrophic factor
US5235043A (en) * 1990-04-06 1993-08-10 Synergen, Inc. Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins
US5169764A (en) * 1990-08-08 1992-12-08 Regeneron Pharmaceuticals, Inc. Multitrophic and multifunctional chimeric neurotrophic factors, and nucleic acids and plasmids encoding the chimeras
DE4139000A1 (de) * 1991-11-27 1993-06-03 Boehringer Mannheim Gmbh Verfahren zur gentechnologischen herstellung von biologisch aktivem ss-ngf

Also Published As

Publication number Publication date
AU697891B2 (en) 1998-10-22
JP3673278B2 (ja) 2005-07-20
DK0772627T3 (da) 2004-11-29
DE69533443T2 (de) 2005-01-20
DE69533443D1 (de) 2004-10-07
US5606031A (en) 1997-02-25
JPH10502804A (ja) 1998-03-17
CA2189659C (en) 2006-12-12
EP0772627A1 (de) 1997-05-14
CA2189659A1 (en) 1995-11-16
ES2230549T3 (es) 2005-05-01
EP0772627A4 (de) 1997-06-11
EP0772627B1 (de) 2004-09-01
AU2432095A (en) 1995-11-29
PT772627E (pt) 2005-01-31
WO1995030686A1 (en) 1995-11-16

Similar Documents

Publication Publication Date Title
ATE275152T1 (de) Die herstellung von biologisch aktiven, rekombinanten und neurotrophem protein
DE69131514D1 (de) Herstellung von biologisch aktiven rekombinanten Mitgliedern der NGF/BDNF-Familie neurotroper Proteine
DE3382837D1 (de) Herstellung von funktionellen, menschlichen Urokinaseproteinen
ATE259828T1 (de) Prosaposin und cytokinabhängige peptide als therapeutisch wirksame mittel
ATE312844T1 (de) Biologisch-aktive bakterizide/permeabilitätserhöhende proteinbruchstücke
DE3750451D1 (de) Rekombinanter menschlicher endothelzellenwachstumsfaktor.
ATE244016T1 (de) Protein der ausseren membran von moraxella catarrhalis omp-106, dessen gensequenz und dessen verwendung
ATE136315T1 (de) Verfahren für die herstellung von polyethylenglykolderivate und modifizierte proteine.
NO971875L (no) Cathepsin 02 protease
DE69632658D1 (de) Expression in der selben Zelle von Polypeptide vom schweinen reproduktiven und respiratorischen Syndrom
EP0224120A3 (de) Markierung von Proteinen und Arzneimittel lieferndes System
ATE246248T1 (de) Anti-hiv-proteine gap31, dap30 und dap32, die sie kodierende dna und ihre therapeutische nutzung
EE200000152A (et) Aminoterminaalselt kärbitud MCP-2 vormid, DNA molekulid, ekspressioonivektor, peremeesrakk, rekombinantne meetod proteiini valmistamiseks, proteiini kasutamine ning farmatseutiline kompositsioon
DE68912624D1 (de) Membran-Verfahren und System für die Herstellung von Stickstoff.
DE3789309D1 (de) Enzymatische membran, verfahren zur herstellung und trennung von peptiden.
DE69324601D1 (de) Multifunktionelle neurotrophe faktoren
NO875069L (no) Hybride proteiner.
NO970325L (no) Fremgangsmåte for fremstilling av biologisk aktivt dimerisk protein
DE3850774D1 (de) Rinder-interleukin-1-alpha.
PT672156E (pt) Promotor de choque termico bovino e respectivas utilizacoes
EP0567785A3 (de) Protein mit Alpha-Glukosidase-Aktivität, DNS mit dessen genetischer Information und Herstellung von Alpha-Glukosidase.
ATE276366T1 (de) Type f botulinum toxin und seine verwendung
EP0676413A3 (de) Interferon alpha/beta bindendes Protein, seine Herstellung und Anwendung.
DE69310382D1 (de) Herstellung von polyoxyalkylen-alpha,omega dicarbonsäuren
ATE216706T1 (de) Peptide des hiv-gag proteins, ihre herstellung und verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0772627

Country of ref document: EP